flecainide has been researched along with Abnormalities, Autosome in 1 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Swan, H | 1 |
| Piippo, K | 1 |
| Viitasalo, M | 1 |
| Heikkilä, P | 1 |
| Paavonen, T | 1 |
| Kainulainen, K | 1 |
| Kere, J | 1 |
| Keto, P | 1 |
| Kontula, K | 1 |
| Toivonen, L | 1 |
1 other study available for flecainide and Abnormalities, Autosome
| Article | Year |
|---|---|
Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Biopsy; Child; Chromosome Aberrations; Chromosome Disorde | 1999 |